Relief News

UPDATE: FDA's Investigation into Patients being Injected with Simulated IV Fluids Continues


February 04, 2015
The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are continuing to investigate multiple instances of Wallcur simulated saline solution being administered to patients. To date, we are aware of more than 40 patients who have received infusions of the simulated saline products. Some of the patients experienced adverse events associated with these products including fever, chills, tremors and headache. FDA and CDC have taken a number of steps to remove the simulated saline products from medical settings, to raise awareness among health care providers, and to provide information to state and local health officials in order to prevent exposure to additional patients. FDA has been working closely with Wallcur to make several changes to their labeling and marketing practices to prevent this from occurring again.
Web Link